News & Updates
Filter by Specialty:

ARBs a good alternative to ACEIs in patients with acute MI
The incidence of death is comparable between patients with acute myocardial infarction (MI) without heart failure (HF) receiving angiotensin II receptor blockers (ARBs) and those taking angiotensin-converting enzyme inhibitors (ACEIs), a study has shown.
ARBs a good alternative to ACEIs in patients with acute MI
20 Nov 2024
SGLT-2 inhibitors help avert death in patients with HFrEF
Use of SGLT-2 inhibitors may reduce the risk of all-cause and cardiovascular (CV) mortality in patients with heart failure (HF) with reduced ejection fraction (HFrEF), reports a study.
SGLT-2 inhibitors help avert death in patients with HFrEF
19 Nov 2024
Fruit, vegetable diet a viable treatment for hypertension
A diet that is rich in fruits and vegetables can help treat individuals with primary hypertension by preventing chronic kidney disease (CKD) progression and reducing the risk of cardiovascular disease (CVD), suggest the results of a recent study.
Fruit, vegetable diet a viable treatment for hypertension
19 Nov 2024
Prompt DOAC therapy after stroke safe for AF patients
Initiating direct oral anticoagulants (DOACs) within 4 days after an ischaemic stroke in patients with atrial fibrillation (AF) is safe and yields similar outcomes as delayed initiation, as shown in the phase 4 OPTIMAS trial.